A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 3,023,984 shares of GILD stock, worth $273 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,023,984
Previous 2,968,143 1.88%
Holding current value
$273 Million
Previous $204 Million 24.47%
% of portfolio
0.18%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$66.59 - $83.99 $3.72 Million - $4.69 Million
55,841 Added 1.88%
3,023,984 $253 Million
Q2 2024

Jul 19, 2024

SELL
$63.15 - $72.88 $32.6 Million - $37.6 Million
-516,559 Reduced 14.82%
2,968,143 $204 Million
Q1 2024

Apr 19, 2024

BUY
$71.58 - $87.29 $731,404 - $891,929
10,218 Added 0.29%
3,484,702 $255 Million
Q4 2023

Jan 30, 2024

BUY
$73.27 - $83.09 $4.22 Million - $4.78 Million
57,537 Added 1.68%
3,474,484 $281 Million
Q3 2023

Oct 30, 2023

SELL
$73.94 - $80.67 $2.73 Million - $2.98 Million
-36,950 Reduced 1.07%
3,416,947 $256 Million
Q2 2023

Jul 31, 2023

SELL
$76.01 - $86.7 $33.1 Million - $37.7 Million
-434,927 Reduced 11.18%
3,453,897 $266 Million
Q1 2023

Apr 27, 2023

SELL
$77.31 - $88.08 $28 Million - $31.9 Million
-362,712 Reduced 8.53%
3,888,824 $323 Million
Q4 2022

Jan 30, 2023

SELL
$62.32 - $89.47 $15.3 Million - $21.9 Million
-245,057 Reduced 5.45%
4,251,536 $365 Million
Q3 2022

Oct 21, 2022

BUY
$59.54 - $68.01 $957,343 - $1.09 Million
16,079 Added 0.36%
4,496,593 $277 Million
Q2 2022

Jul 26, 2022

SELL
$57.72 - $65.01 $1.99 Million - $2.24 Million
-34,519 Reduced 0.76%
4,480,514 $277 Million
Q1 2022

Apr 27, 2022

SELL
$57.92 - $72.58 $481,083 - $602,849
-8,306 Reduced 0.18%
4,515,033 $268 Million
Q4 2021

Feb 02, 2022

BUY
$64.88 - $73.64 $37.9 Million - $43 Million
583,717 Added 14.82%
4,523,339 $328 Million
Q3 2021

Oct 25, 2021

SELL
$67.69 - $73.03 $13.3 Million - $14.3 Million
-195,808 Reduced 4.73%
3,939,622 $275 Million
Q2 2021

Aug 02, 2021

SELL
$63.47 - $69.35 $43.2 Million - $47.3 Million
-681,373 Reduced 14.15%
4,135,430 $285 Million
Q1 2021

Apr 30, 2021

SELL
$60.0 - $68.46 $14.7 Million - $16.8 Million
-245,343 Reduced 4.85%
4,816,803 $311 Million
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $35.9 Million - $40.9 Million
-633,599 Reduced 11.12%
5,062,146 $295 Million
Q3 2020

Oct 30, 2020

SELL
$62.1 - $78.08 $2.67 Million - $3.36 Million
-43,074 Reduced 0.75%
5,695,745 $360 Million
Q2 2020

Jul 27, 2020

BUY
$72.34 - $84.0 $34.3 Million - $39.8 Million
473,677 Added 9.0%
5,738,819 $442 Million
Q1 2020

Apr 27, 2020

BUY
$62.63 - $80.22 $2.06 Million - $2.63 Million
32,841 Added 0.63%
5,265,142 $394 Million
Q4 2019

Jan 31, 2020

BUY
$61.62 - $67.78 $4.75 Million - $5.22 Million
77,087 Added 1.5%
5,232,301 $340 Million
Q3 2019

Oct 31, 2019

BUY
$62.51 - $69.0 $3.43 Million - $3.79 Million
54,910 Added 1.08%
5,155,214 $327 Million
Q2 2019

Jul 29, 2019

SELL
$61.87 - $69.38 $7.02 Million - $7.87 Million
-113,456 Reduced 2.18%
5,100,304 $345 Million
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $10.5 Million - $11.7 Million
167,292 Added 3.32%
5,213,760 $339 Million
Q4 2018

Feb 06, 2019

BUY
$60.54 - $79.0 $48.4 Million - $63.2 Million
800,268 Added 18.85%
5,046,468 $312 Million
Q3 2018

Nov 07, 2018

BUY
$71.28 - $78.92 $4.89 Million - $5.41 Million
68,555 Added 1.64%
4,246,200 $328 Million
Q2 2018

Aug 01, 2018

BUY
$64.88 - $75.68 $17.9 Million - $20.9 Million
275,803 Added 7.07%
4,177,645 $296 Million
Q1 2018

May 01, 2018

BUY
$72.84 - $88.8 $4.12 Million - $5.02 Million
56,537 Added 1.47%
3,901,842 $294 Million
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $5.29 Million - $6.21 Million
74,410 Added 1.97%
3,845,305 $275 Million
Q3 2017

Nov 07, 2017

SELL
$72.11 - $85.47 $3.44 Million - $4.08 Million
-47,702 Reduced 1.25%
3,770,895 $306 Million
Q2 2017

Aug 07, 2017

BUY
N/A
3,818,597
3,818,597 $270 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.